UB’s Clinical and Translational Science Institute (CTSI) has recognized two Jacobs School of Medicine and Biomedical Sciences faculty members for their clinical research work.
The awards, now in their third year, honor outstanding accomplishments in clinical research performed at a Buffalo Translational Consortium (BTC) institution with investigators from the University at Buffalo or Roswell Park Comprehensive Cancer Center serving as the lead authors. The research must have been published or in press in the past 12 months.
Jeffrey M. Lackner, PsyD, professor of medicine and chief of the Division of Behavioral Medicine, received the BTC’s 2018 Clinical Research Achievement Award for a study titled “Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome,” published in the July 2018 issue of Gastroenterology.
Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, was recognized as an award finalist for a study titled “Efficacy and Safety of Dapaglifloxin in Patients with Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study,” published in the December 2018 issue of Diabetes Care.